Abstract
In the recent years, a large number of potential biomarkers for Chronic Obstructive Pulmonary Disease (COPD) have been described. One of the important biomarkers is Surfactant Protein D (SPD) since serum SPD levels have been associated with lung function or health status in patients with severe COPD. Several interesting evidences of the protein and gene polymorphisms have been described. The present review highlights the current literature, recent patents and, future prospects of this important collection.
Keywords: Biomarkers, COPD, exacerbations, genetic polymorphism, lung surfactant, SP-D.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title:Surfactant Protein D in Chronic Obstructive Pulmonary Disease (COPD)
Volume: 8 Issue: 1
Author(s): Dolores Moreno, Alexis Garcia, Diego Lema and Juan B. De Sanctis
Affiliation:
Keywords: Biomarkers, COPD, exacerbations, genetic polymorphism, lung surfactant, SP-D.
Abstract: In the recent years, a large number of potential biomarkers for Chronic Obstructive Pulmonary Disease (COPD) have been described. One of the important biomarkers is Surfactant Protein D (SPD) since serum SPD levels have been associated with lung function or health status in patients with severe COPD. Several interesting evidences of the protein and gene polymorphisms have been described. The present review highlights the current literature, recent patents and, future prospects of this important collection.
Export Options
About this article
Cite this article as:
Moreno Dolores, Garcia Alexis, Lema Diego and De Sanctis B. Juan, Surfactant Protein D in Chronic Obstructive Pulmonary Disease (COPD), Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2014; 8 (1) . https://dx.doi.org/10.2174/1872214808666140209142640
DOI https://dx.doi.org/10.2174/1872214808666140209142640 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Current Medicinal Chemistry - Central Nervous System Agents Retinoids as Differentiating Agents in Oncology: A Network of Interactions with Intracellular Pathways as the Basis for Rational Therapeutic Combinations
Current Pharmaceutical Design Biosimilars: Current Scientific and Regulatory Considerations
Current Clinical Pharmacology Mechanisms of Herb-Induced Nephrotoxicity
Current Medicinal Chemistry A Proteomics Perspective: From Animal Welfare to Food Safety
Current Protein & Peptide Science Multifaceted Synthesis, Properties and Applications of Polyurethanes and its Composites
Current Organic Chemistry Editorial: “Ah, Wherefore with Infection Should he Live?”: Microbial Virulence Factors in Diabetic Foot Ulceration
Current Vascular Pharmacology Molecular Chaperone Activity and Biological Regulatory Actions of the TPR-Domain Immunophilins FKBP51 and FKBP52
Current Protein & Peptide Science Integrated Biomarkers for Depression in Alzheimer’s Disease: A Critical Review
Current Alzheimer Research Water and Ion Channels: Crucial in the Initiation and Progression of Apoptosis in Central Nervous System?
Current Neuropharmacology Could Growth Factor-Mediated Extracellular Matrix Deposition and Degradation Offer the Ground for Directed Pharmacological Targeting in Fibrosarcoma?
Current Medicinal Chemistry Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer
Anti-Cancer Agents in Medicinal Chemistry Relevance of Excitable Media Theory and Retinal Spreading Depression Experiments in Preclinical Pharmacological Research
Current Neuropharmacology The Pleiotropic Effects of Inducible Nitric Oxide Synthase (iNOS) on the Physiology and Pathology of Penile Erection
Current Pharmaceutical Design Unique Coronary Artery Disease Differences in Women as Related to Revascularization
Current Medicinal Chemistry Alkaloids from Piper: A Review of its Phytochemistry and Pharmacology
Mini-Reviews in Medicinal Chemistry Increased ACE2, sRAGE, and Immune Activation, but Lowered Calcium and Magnesium in COVID-19
Recent Advances in Inflammation & Allergy Drug Discovery Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Anti-Cancer Agents in Medicinal Chemistry The Ultrasonographic Diagnosis of Polycystic Ovary Syndrome
Current Medical Imaging Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules
Current Medicinal Chemistry